Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Bueren, Juan A  [Clear All Filters]
2023
Sanchez-Guijo F, Avendaño-Solá C, Badimon L, Bueren JA, Canals JM, Delgadillo J, Delgado J, Eguizabal C, Fernández-Santos M-E, García-Olmo D, et al. Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV). Bone Marrow Transplant. 2023.
2022
Casado JA, Valeri A, Sanchez-Domínguez R, Vela P, Lopez A, Navarro S, Alberquilla O, Hanenberg H, Pujol R, Segovia JC, et al. Upregulation of NKG2D ligands impairs hematopoietic stem cell function in Fanconi anemia. J Clin Invest. 2022.
2021
Lopez-Santalla M, Bueren JA, Garin MI. Mesenchymal stem/stromal cell-based therapy for the treatment of rheumatoid arthritis: An update on preclinical studies. EBioMedicine. 2021;69:103427.
Ramírez MJosé, Pujol R, Trujillo-Quintero JPablo, Minguillón J, Bogliolo M, Rio P, Navarro S, Casado JA, Badell I, Carrasco E, et al. Natural gene therapy by reverse mosaicism leads to improved hematology in Fanconi anemia patients. Am J Hematol. 2021.
2019
Quintana-Bustamante O, Fañanas-Baquero S, Orman I, Torres R, Duchateau P, Poirot L, Gouble A, Bueren JA, Segovia JC. Gene editing of PKLR gene in human hematopoietic progenitors through 5' and 3' UTR modified TALEN mRNA. PLoS One. 2019;14(10):e0223775.
2016
Pulecio J, Alejo-Valle O, Capellera-Garcia S, Vitaloni M, Rio P, Mejia-Ramirez E, Caserta I, Bueren JA, Flygare J, Raya A. Direct Conversion of Fibroblasts to Megakaryocyte Progenitors. Cell Rep. 2016;17(3):671-683.
2014
Leon-Rico D, Aldea M, Sanchez R, Segovia JC, Weiss LA, Hidalgo A, Bueren JA, Almarza E. Reduced expression of CD18 leads to the in vivo expansion of hematopoietic stem cells in mouse bone marrow. Stem Cells. 2014.